3KNX
HCV NS3 protease domain with P1-P3 macrocyclic ketoamide inhibitor
3KNX の概要
エントリーDOI | 10.2210/pdb3knx/pdb |
関連するPDBエントリー | 3EYD |
分子名称 | HCV NS3 Protease, HCV NS4a peptide, ZINC ION, ... (6 entities in total) |
機能のキーワード | hepatitis c virus, ns3 protease domain, serine protease, macrocyclic ketoamide inhibitor, atp-binding, envelope protein, helicase, hydrolase, membrane, nucleotide-binding, rna replication, transmembrane, viral protein |
由来する生物種 | Hepatitis C virus subtype 1a 詳細 |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 48192.44 |
構造登録者 | Venkatraman, S.,Velazquez, F.,Wu, W.,Blackman, M.,Chen, K.X.,Bogen, S.,Nair, L.,Tong, X.,Chase, R.,Hart, A.,Agrawal, S.,Pichardo, J.,Prongay, A.,Cheng, K.-C.,Girijavallabhan, V.,Piwinski, J.,Shih, N.-Y.,Njoroge, F.G. (登録日: 2009-11-12, 公開日: 2010-10-27, 最終更新日: 2024-04-03) |
主引用文献 | Venkatraman, S.,Velazquez, F.,Wu, W.,Blackman, M.,Chen, K.X.,Bogen, S.,Nair, L.,Tong, X.,Chase, R.,Hart, A.,Agrawal, S.,Pichardo, J.,Prongay, A.,Cheng, K.C.,Girijavallabhan, V.,Piwinski, J.,Shih, N.Y.,Njoroge, F.G. Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease. J.Med.Chem., 52:336-346, 2009 Cited by PubMed Abstract: Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, and affects more than 200 million people worldwide. Although combination therapy of interferon-alpha and ribavirin is reasonably successful in treating majority of genotypes, its efficacy against the predominant genotype (genotype 1) is moderate at best, with only about 40% of the patients showing sustained virological response. Herein, the SAR leading to the discovery of a series of ketoamide derived P(1)-P(3) macrocyclic inhibitors that are more potent than the first generation clinical candidate, boceprevir (1, Sch 503034), is discussed. The optimization of these macrocyclic inhibitors identified a P(3) imide capped analogue 52 that was 20 times more potent than 1 and demonstrated good oral pharmacokinetics in rats. X-ray structure of 52 bound to NS3 protease and biological data are also discussed. PubMed: 19102654DOI: 10.1021/jm800940u 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.65 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
![ダウンロード](/newweb/media/icons/dl.png)